These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4582165)

  • 1. [Metabolic disorders caused by intravenous administration of sorbitol or fructose].
    Bode JC
    Internist (Berl); 1973 Jul; 14(7):335-6. PubMed ID: 4582165
    [No Abstract]   [Full Text] [Related]  

  • 2. [Undesirable metabolic effects following the administration of higher doses of fructose and sorbitol].
    Bode JC
    Infusionstherapie (1973); 1974 Oct; 1(7):558-63. PubMed ID: 4219393
    [No Abstract]   [Full Text] [Related]  

  • 3. [Undesirable metabolic effects following the administration of larger doses of fructose and sorbitol].
    Bode JC
    Infusionstherapie (1973); 1974 Oct; 1(7):558-63. PubMed ID: 4219394
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sugar substitutes in the diabetic diet].
    Mehnert H
    Int Z Vitam Ernahrungsforsch Beih; 1976; 15():295-324. PubMed ID: 783058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible side effects of glucose, fructose, sorbitol and xylitol in man.
    Förster H
    Int Z Vitam Ernahrungsforsch Beih; 1976; 15():116-30. PubMed ID: 133999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side effects of sugar substitutes during intravenous administration.
    Thomas DW; Edwards JB; Edwards RG
    Nutr Metab; 1975; 18 Suppl 1():227-41. PubMed ID: 1165865
    [No Abstract]   [Full Text] [Related]  

  • 7. [The behavior of glucose-, fructose- and sorbitol metabolism in patients with and without liver diseases before, during and after intravenous infusion of sorbitol].
    STUHLFAUTH K; MEHNERT H; PETTE C
    Med Welt; 1960 Jun; 25():1367-70. PubMed ID: 13835436
    [No Abstract]   [Full Text] [Related]  

  • 8. Limits on infusions of laevulose and sorbitol.
    Med J Aust; 1976 Apr; 1(16):582. PubMed ID: 933958
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fatal consequences of fructose infusion in undiagnosed fructose intolerance].
    Rey M; Behrens R; Zeilinger G
    Dtsch Med Wochenschr; 1988 Jun; 113(23):945-7. PubMed ID: 3378502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dangers of intravenous fructose and sorbitol.
    Van den Berghe G; Hers HG
    Acta Paediatr Belg; 1978; 31(3):115-23. PubMed ID: 101018
    [No Abstract]   [Full Text] [Related]  

  • 11. [Death following fructose and sorbitol infusions].
    Wagner K; Wolf AS
    Anaesthesist; 1984 Nov; 33(11):573-8. PubMed ID: 6517265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Critical comments on reports of fatalities in hereditary fructose intolerance in adulthood from the viewpoint of neuroanesthesia].
    Panning B; Piepenbrock S
    Anasth Intensivther Notfallmed; 1988 Aug; 23(4):217-9. PubMed ID: 3052154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The dangers of fructose-sorbitol infusions].
    Karrenberg R; Stober HD
    Anaesthesiol Reanim; 1990; 15(3):181-7. PubMed ID: 2393482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible lactic acidosis associated with repeated intravenous infusions of sorbitol and ethanol.
    Batstone GF; Alberti KG; Dewar AK
    Postgrad Med J; 1977 Sep; 53(623):567-9. PubMed ID: 22069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fructose metabolism disorders and infusions].
    Palyza V; Bocková M
    Vnitr Lek; 1992 Aug; 38(8):814-21. PubMed ID: 1455766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Repeated perioperative administration of fructose and sorbitol in a female patient with hereditary fructose intolerance [HFI)].
    Sachs M; Asskali F; Förster H; Encke A
    Z Ernahrungswiss; 1993 Mar; 32(1):56-66. PubMed ID: 8484270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dangers of intravenous fructose.
    Woods HF; Alberti KG
    Lancet; 1972 Dec; 2(7791):1354-7. PubMed ID: 4118217
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic disease. Time for fructose solutions to go.
    Collins J
    Lancet; 1993 Mar; 341(8845):600. PubMed ID: 8094835
    [No Abstract]   [Full Text] [Related]  

  • 19. [The sugar substitutes fructose and sorbite: an unnecessary risk in parenteral nutrition].
    Keller U
    Schweiz Med Wochenschr; 1989 Jan; 119(4):101-6. PubMed ID: 2493157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genuine adverse effects following the infusion of sugar-exchange substances?].
    Förster H
    Dtsch Med Wochenschr; 1973 Apr; 98(16):839-44. PubMed ID: 4633015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.